Logo image of ZCAR

ZOOMCAR HOLDINGS INC (ZCAR) Stock Fundamental Analysis

NASDAQ:ZCAR - Nasdaq - US45784G3092 - Common Stock - Currency: USD

4.95  -1 (-16.81%)

After market: 5 +0.05 (+1.01%)

Fundamental Rating

0

We assign a fundamental rating of 0 out of 10 to ZCAR. ZCAR was compared to 41 industry peers in the Ground Transportation industry. ZCAR may be in some trouble as it scores bad on both profitability and health. ZCAR does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

In the past year ZCAR has reported negative net income.
ZCAR had a negative operating cash flow in the past year.
ZCAR Yearly Net Income VS EBIT VS OCF VS FCFZCAR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 -10M -20M -30M

1.2 Ratios

Looking at the Return On Assets, with a value of -265.75%, ZCAR is doing worse than 92.68% of the companies in the same industry.
Industry RankSector Rank
ROA -265.75%
ROE N/A
ROIC N/A
ROA(3y)-125.24%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ZCAR Yearly ROA, ROE, ROICZCAR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 100 -100 -200 -300

1.3 Margins

With a Gross Margin value of 32.93%, ZCAR is not doing good in the industry: 60.98% of the companies in the same industry are doing better.
ZCAR does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 32.93%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ZCAR Yearly Profit, Operating, Gross MarginsZCAR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 -100 -200 -300

0

2. Health

2.1 Basic Checks

ZCAR does not have a ROIC to compare to the WACC, probably because it is not profitable.
ZCAR has less shares outstanding than it did 1 year ago.
Compared to 1 year ago, ZCAR has a worse debt to assets ratio.
ZCAR Yearly Shares OutstandingZCAR Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 10M 20M 30M
ZCAR Yearly Total Debt VS Total AssetsZCAR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 50M 100M 150M 200M

2.2 Solvency

ZCAR has an Altman-Z score of -63.11. This is a bad value and indicates that ZCAR is not financially healthy and even has some risk of bankruptcy.
ZCAR has a Altman-Z score of -63.11. This is amonst the worse of the industry: ZCAR underperforms 95.12% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -63.11
ROIC/WACCN/A
WACC5.93%
ZCAR Yearly LT Debt VS Equity VS FCFZCAR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 0 50M 100M 150M 200M

2.3 Liquidity

A Current Ratio of 0.11 indicates that ZCAR may have some problems paying its short term obligations.
With a Current ratio value of 0.11, ZCAR is not doing good in the industry: 95.12% of the companies in the same industry are doing better.
ZCAR has a Quick Ratio of 0.11. This is a bad value and indicates that ZCAR is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.11, ZCAR is doing worse than 95.12% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.11
Quick Ratio 0.11
ZCAR Yearly Current Assets VS Current LiabilitesZCAR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 10M 20M 30M

1

3. Growth

3.1 Past

The earnings per share for ZCAR have decreased strongly by -212.06% in the last year.
ZCAR shows a strong growth in Revenue. In the last year, the Revenue has grown by 276.54%.
EPS 1Y (TTM)-212.06%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-115.53%
Revenue 1Y (TTM)276.54%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%1.16%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ZCAR Yearly Revenue VS EstimatesZCAR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2024 2M 4M 6M 8M

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ZCAR. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ZCAR Price Earnings VS Forward Price EarningsZCAR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ZCAR Per share dataZCAR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10 -20 -30 -40

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for ZCAR!.
Industry RankSector Rank
Dividend Yield N/A

ZOOMCAR HOLDINGS INC

NASDAQ:ZCAR (5/7/2025, 8:00:02 PM)

After market: 5 +0.05 (+1.01%)

4.95

-1 (-16.81%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupTransportation
GICS IndustryGround Transportation
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners1.06%
Inst Owner Change0.22%
Ins Owners3.83%
Ins Owner Change0%
Market Cap3.51M
AnalystsN/A
Price TargetN/A
Short Float %20.62%
Short Ratio0.08
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.39
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-23.41
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-26.45
FCFYN/A
OCF(TTM)-26.34
OCFYN/A
SpS12.84
BVpS-44.32
TBVpS-44.34
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -265.75%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 32.93%
FCFM N/A
ROA(3y)-125.24%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover1.14
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.11
Quick Ratio 0.11
Altman-Z -63.11
F-Score4
WACC5.93%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-212.06%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-115.53%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)276.54%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%1.16%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y15.77%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-1496.04%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-1489.12%
OCF growth 3YN/A
OCF growth 5YN/A